NOVALUBEĀ® Sodium Stearyl Fumarate: A Game-Changer in Tablet Formulations
Ā Discover how NOVALUBEĀ® Sodium Stearyl Fumarate enhances pharmaceutical tablet quality and regulatory compliance. Ideal for formulation scientists and procurement heads.
NOVALUBEĀ® SODIUM STEARYL FUMARATE: The Silent Architect Behind Robust Tablet Formulations
In pharmaceutical tablet production, excipients may not grab headlinesābut their impact on product success is profound. Among these, Sodium Stearyl Fumarate (SSF) has steadily emerged as a gold-standard lubricant for modern solid dosage formulations. In this blog, we explore how NOVALUBEĀ® Sodium Stearyl Fumarate, manufactured by Nitika Pharma, is revolutionizing tablet manufacturing with its exceptional performance, consistency, and regulatory advantage.
What is Sodium Stearyl Fumarate (SSF), and Why Does It Matter?
Sodium Stearyl Fumarate is a hydrophilic, anionic lubricant primarily used in direct compression and capsule filling. Unlike traditional lubricants such as magnesium stearate, SSF doesn't interfere with API dissolution or bioavailabilityāmaking it a preferred choice in high-performance, compliance-driven formulations.
Key Functional Roles of SSF in Formulations:
Reduces friction during tableting
Prevents sticking to punches and dies
Enhances dissolution profile compared to hydrophobic lubricants
Improves stability for moisture-sensitive APIs
These properties position NOVALUBEĀ® as a critical enabler for robust, reproducible, and scalable formulations.
Why NOVALUBEĀ® SSF is Earning Trust Across Global Pharma Markets
Nitika Pharmaās NOVALUBEĀ® is not just another SSFāitās an engineered solution designed for GMP-regulated, highly regulated markets.
ā Unique Differentiators of NOVALUBEĀ®:
Pharma-grade purity (conforming to Ph. Eur, USP, JP)
Manufactured in a dedicated GMP-certified facility with full traceability
Particle size optimized for uniform blend and compressibility
DMF available, supporting fast-track regulatory approvals
Backed by Nitika's consistent global supply chain and responsive customer support
āAs regulatory scrutiny increases, excipients like NOVALUBEĀ® that combine functionality and compliance are not optionalāthey're essential.ā
Explore detailed specifications on Nitika Pharmaās official product page.
Use Cases That Highlight NOVALUBEĀ®'s Value
Letās explore a few scenarios where NOVALUBEĀ® can be a game-changer:
š¹ 1. High-Speed Compression Lines
Fast production lines generate friction and heatārisking punch damage and content uniformity issues. NOVALUBEĀ® provides clean ejection and consistent tablet weight.
š¹ 2. API-Sensitive to Hydrophobic Excipients
Hydrophobic lubricants like Mg stearate can delay dissolution of poorly soluble APIs. NOVALUBEĀ®ās hydrophilic profile ensures faster disintegration.
š¹ 3. Regulatory Audits and Global Submissions
NOVALUBEĀ® is supported by a well-structured DMF and CoAs, streamlining USFDA, EMA, and PMDA approvals.
Formulation Scientistsā Checklist for Choosing Lubricants
When selecting a tablet lubricant, formulation and process scientists must evaluate:
Compatibility with APIs
Effect on dissolution rate
Lubrication efficiency at low concentrations
Regulatory support (e.g., DMF, CoA, stability data)
Manufacturing flexibility (ODTs, MR, chewables, etc.)
NOVALUBEĀ® ticks all these boxesāespecially important for teams formulating multi-country dossiers.
Global Trends Elevating SSF Demand
The market for high-performance excipients is booming. According to a 2023 Grand View Research report, the demand for lubricants that minimize variability and support bioequivalence studies is on the rise.
Driving Forces:
Surge in high-potency drugs requiring clean-release excipients
Rising preference for direct compression methods
Global shift toward risk-based formulation development
NOVALUBEĀ® for Procurement Teams: Assured Supply Meets Regulatory Clarity
For sourcing professionals, the question is not just what you buyābut who you buy it from. NOVALUBEĀ® is backed by:
Dedicated manufacturing blocks at Nitikaās EU-GMP-compliant sites
Track record of exports to 60+ countries
Agile logistics with real-time batch status updates
Global samples, regulatory document packs, and technical support Frequently Asked Questions (FAQ)
Q1. Can NOVALUBEĀ® be used in ODT and chewable tablets? Yes, it is ideal due to its hydrophilic nature and lack of unpleasant taste.
Q2. What is the recommended concentration of NOVALUBEĀ® in formulations? Typically between 0.5ā2%, depending on formulation specifics.
Q3. Does NOVALUBEĀ® comply with regulatory requirements for the US, EU, and Japan? Absolutely. It complies with USP/NF, Ph. Eur, JP and comes with full regulatory documentation (DMF, CoA, stability data).
Final Word: Choose NOVALUBEĀ® for Formulations That WorkāEvery Time
For formulation scientists striving for robust, high-speed tablet performance, and for procurement teams demanding quality with documentation clarity, NOVALUBEĀ® Sodium Stearyl Fumarate is more than an excipientāitās a strategic asset.
ā Ready to Reformulate With Confidence?
Letās explore how NOVALUBEĀ® can elevate your formulations. Reach out to Nitikaās technical or sales team for samples, CoAs, or regulatory packs tailored to your region and formulation needs.
š Contact Us Now to initiate a technical discussion or procurement inquiry.
Ā Ā š© Enquiry |š +91 7122554812 |Ā š https://nitikapharma.com
Sodium Stearyl Fumarate
Tablet formulation lubricant
Hydrophilic excipient
Pharma-grade SSF
Regulatory-compliant excipients













